Your browser doesn't support javascript.
Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
Ngiam, Jinghao Nicholas; Al-Mubaarak, Abdurrahmaan; Maurer-Stroh, Sebastian; Tambyah, Paul Anantharajah.
  • Ngiam JN; Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore.
  • Al-Mubaarak A; Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore.
  • Maurer-Stroh S; Bioinformatics Institute and Infectious Diseases Labs, Agency for Science Technology and Research; Department of Biological Sciences, Singapore.
  • Tambyah PA; Division of Infectious Diseases, Department of Medicine, National University Health System; Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Singapore Med J ; 2022 Dec 01.
Artículo en Inglés | MEDLINE | ID: covidwho-2202122
ABSTRACT
All pandemic viruses have eventually adapted to human hosts so that they become more transmissible and less virulent. The XBB Omicron subvariant is rapidly becoming the dominant strain of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Singapore from October 2022 and is one of several variants circulating globally with the potential to dominate autumn/winter waves in different countries. The XBB Omicron subvariant has demonstrated increased transmissibility through an apparent propensity for immune evasion. This is to be expected in the natural evolution of a virus in a population highly vaccinated with a vaccine targeting the spike protein of the original Wuhan strain of the virus. This review explores the important implications of the rising prevalence of the SARS-CoV-2 Omicron subvariant for public health in Singapore and beyond.
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tipo de estudio: Estudio observacional Tópicos: Vacunas / Variantes Idioma: Inglés Año: 2022 Tipo del documento: Artículo País de afiliación: Singaporemedj.SMJ-2022-180

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tipo de estudio: Estudio observacional Tópicos: Vacunas / Variantes Idioma: Inglés Año: 2022 Tipo del documento: Artículo País de afiliación: Singaporemedj.SMJ-2022-180